Cases & Deals

Apposite Capital invests in Ambrx

Clients Apposite Capital LLP

Jones Day advised Apposite Capital LLP in connection with its purchase of Series C Convertible Preferred Stock in a private placement by Ambrx, Inc., a biopharmaceutical company.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.